Related Experiment Video
Updated: Jul 20, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
Coping with new challenges in acute coronary syndromes
Pierre Théroux1, Benoît Labarthe
1Montreal Heart Institute and University of Montreal, Montreal, Quebec. Pierre.Theroux@ICM-MHI.org
Insights
Acute coronary syndromes (ACS) remain a significant health challenge despite established guidelines. Future strategies require improved risk stratification, targeted therapies, and a broader view of coronary artery disease management.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Practice Guidelines
Background:
- Acute coronary syndromes (ACS) are recognized clinical diagnoses with extensive guidelines.
- Despite this, ACS continues to present challenges due to high prevalence, morbidity, and mortality.
- Current management strategies, often invasive, place a significant burden on healthcare systems.
Purpose of the Study:
- To address the persistent challenges posed by acute coronary syndromes.
- To propose advancements in risk stratification, therapeutic interventions, and patient management.
- To integrate ACS within a comprehensive understanding of coronary artery disease.
Main Methods:
- Review and analysis of current diagnostic and management algorithms for ACS.
- Exploration of novel approaches to risk stratification incorporating patient-specific factors.
- Evaluation of emerging antithrombotic therapies and revascularization strategies.
- Consideration of advanced blood markers and imaging techniques for targeted treatment.
Main Results:
- Current risk stratification schemes may be insufficient for optimal patient management.
- There is a need for more effective antithrombotic therapies with a manageable bleeding risk.
- Personalized medical and revascularization therapies hold promise for improved outcomes.
Conclusions:
- Enhanced risk stratification beyond current algorithms is crucial for managing ACS.
- Development of safer and more effective antithrombotic agents is needed.
- Targeted therapies based on individual pathophysiology, identified through novel diagnostics, are essential for advancing ACS care.
Abstract:
The acute coronary syndromes have become well-established clinical entities and are used as working diagnoses tied in with elaborate investigation and treatment practice guidelines. However, these syndromes remain challenging because their prevalence, morbidity and mortality remain high. Furthermore, these syndromes are demanding on the health care system because an early invasive management strategy is recommended for most patients with these conditions. Coping with these challenges requires the following initiatives: stepping beyond current diagnostic and management algorithms to a better performing risk stratification scheme that considers specific patient risk factors in addition to the disease risk, and a reintegration of acute coronary syndromes into the more global perspective of coronary artery disease; more effective antithrombotic therapy that does not further compromise bleeding risk, or drugs that control thrombogenic stimuli; and medical and revascularization therapies targeted to more specific individual pathophysiologies identified by novel blood markers and imaging techniques.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease V: Interprofessional Care